Elisabeth Leiderman
2022
In 2022, Elisabeth Leiderman earned a total compensation of $751.9K as Former Chief Financial Officer and Head of Corporate Development at Decibel Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
Option Awards | $137,004 |
---|---|
Salary | $307,692 |
Other | $307,239 |
Total | $751,936 |
Leiderman received $307.7K in salary, accounting for 41% of the total pay in 2022.
Leiderman also received $137K in option awards and $307.2K in other compensation.
Rankings
In 2022, Elisabeth Leiderman's compensation ranked 3,598th out of 5,625 executives tracked by ExecPay. In other words, Leiderman earned more than 36.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,598 | 36th |
Manufacturing | 2,042 | 33rd |
Chemicals And Allied Products | 976 | 29th |
Drugs | 913 | 29th |
Pharmaceutical Preparations | 663 | 29th |
Leiderman's colleagues
We found three more compensation records of executives who worked with Elisabeth Leiderman at Decibel Therapeutics in 2022.